Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

How can bone turnover markers be best utilized for prediction of skeletal events in patients with solid tumors?

Nature Clinical Practice Oncology volume 2, pages 242–243 (2005)Cite this article

boxed-textBrown JE et al. (2005) Bone turnove markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst 97: 59–69

Background

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Fohr B et al. (2003) Clinical review 165: Markers of bone remodeling in metastatic bone disease. J Clin Endocrinol Metab 88: 5059–5075

    Article  CAS  Google Scholar 

  2. Coleman RE (2002) The clinical use of bone resorption markers in patients with malignant bone disease. Cancer 94: 2521–2533

    Article  Google Scholar 

  3. Lipton A et al. (2001) Bone markers in the management of metastatic bone disease. Cancer Treat Rev 27: 181–185

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Assistant Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Cellular and Structural Biology and Director of Orthopedic Research at the University of Texas Health Science Center, San Antonio, TX, USA

    Gregory R Mundy

Authors
  1. Gregory R Mundy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregory R Mundy.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Glossary

SKELETAL-RELATED EVENT

Pathologic bone fracture, spinal-cord compression, bone surgery or bone radiotherapy

ECOG PERFORMANCE STATUS

A 0 (fully active) to 5 (dead) scoring system to assess the wellbeing of cancer patients and their ability to perform ordinary tasks

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mundy, G. How can bone turnover markers be best utilized for prediction of skeletal events in patients with solid tumors?. Nat Rev Clin Oncol 2, 242–243 (2005). https://doi.org/10.1038/ncponc0167

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0167

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing